ABCB1 and lymphoma: It has been demonstrated that a selenoanhydride derivative and some selenoester derivatives have potent anticancer activity against ABCB1 expressing in MDR mouse T-lymphoma cells and MDR colon adenocarcinoma cells due to ABCB1 inhibition and apoptosis induction [15].